Industry Makes Its Case To Trump In Effort To Sidestep Tariffs

AAM, PhRMA And BIO Submit Comments On 232 Investigation

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.